Latest International Business News

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.

Straker Limited has won a significant contract to provide English-to-French translation services for the European Union, reinforcing its position in AI-powered language solutions.

VEEM Ltd has secured $14 million through a placement to fuel its expansion in defence manufacturing, including a landmark US$33 million licence agreement with Northrop Grumman. The company is poised to accelerate revenue in the second half of FY26 as it deepens ties with major US defence contractors.

Vection Technologies reports a 60% revenue surge in 1H25, secures a $21 million equity raise, and strengthens its position in defence AI and spatial computing with a robust $75 million sales pipeline.

Mayne Pharma has publicly refuted recent media claims about plans to close its Salisbury manufacturing site, clarifying its position amid ongoing regulatory scrutiny of its Scheme transaction with Cosette.

PEXA Group Limited reported a 16% revenue increase to $393.6 million for FY25, driven by growth across its Australian Exchange, UK International business, and Digital Solutions segments. Despite a statutory net loss of $76.1 million due to impairments and deferred tax derecognition, core EBITDA rose 21% with improved margins.

SPC Global Holdings Ltd has reported FY25 proforma results exceeding guidance with a normalised EBITDA of $30.3 million, setting the stage for ambitious growth and international expansion in FY26.

McPherson's Limited reported a 3.9% revenue decline in FY25 driven by exiting lower-margin brands, while core brands grew 1.9%. The company posted a statutory net loss of $15 million, weighed down by significant impairments as it completes a major operating model transformation.

RocketBoots Limited has secured a significant trial contract with one of Mexico's largest retail banks, marking a key step in its international expansion and potential revenue growth.

Telstra has reported robust FY25 financial results, driven by underlying EBITDA growth across key segments and disciplined cost management, while announcing an increased dividend and a fresh $1 billion share buy-back.